Potent inhibition of human cytochrome P450, 2D6, 2C9 isoenzymes by grapefruit juice and its furocoumarins

被引:64
|
作者
Girennavar, B. [1 ]
Jayaprakasha, G. K. [1 ]
Patil, B. S. [1 ]
机构
[1] Texas A&M Univ, Dept Hort Sci, Vegetable & Fruit Improvement Ctr, College Stn, TX 77843 USA
关键词
bioavallabillty modulators; cytochrome P450 inhibitors; grapefrult juice-drug interaction; phase I enzymes;
D O I
10.1111/j.1750-3841.2007.00483.x
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The cytochrome P450 enzyme family is the most abundant and responsible for the metabolism of more than 60% of currently marketed drugs and Is considered central in many clinically Important drug interactions. Seven different grapefruit and pummelo juices as well as 5 furocoumarins isolated from grapefruit juice were evaluated at different concentration on cytochrome P450 3A4 (CYP3A4), cytochrome P450 2C9 (CYP2C9), and cytochrome P450 2D6 (CYP2D6) isoenzyme activity. Grapefruit and pummelo juices were found to be potent Inhibitors of cytochrome CYP3A4 and CYP2C9 isoenzymes at 25% concentration, while CYP2D6 is inhibited significantly low at all the tested concentration of juices, (P < 0.05). Among the, 5 furocoumarins tested, the inhibitory potency was in the order of paradisin A > dihydroxybergamottin > hergamottin > bergaptol > geranylcoumarin at 0.1 mu M to 0.1 mM concentrations. The IC50 value was lowest for paradisin A for CYP3A4 with 0.11 mu M followed by DRB for CYP2C9 with 1.58 mu M.
引用
收藏
页码:C417 / C421
页数:5
相关论文
共 50 条
  • [1] Inhibition models for cytochrome P450 1A2, 2C9, 2D6, and 3A4
    Zhuang, Dechuan
    Zhang, Jinhua
    Fraczkiewicz, Robert
    Bolger, Michael B.
    Waldman, Marvin
    Woltosz, Walter S.
    Enslein, Kurt
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [2] Identification of cytochrome P450 2D6 and 2C9 substrates and inhibitors by QSAR analysis
    Jonsdottir, Svava Osk
    Ringsted, Tine
    Nikolov, Nikolai G.
    Dybdahl, Marianne
    Wedebye, Eva Bay
    Niemela, Jay R.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (06) : 2042 - 2053
  • [3] Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition
    Gong, Changda
    Feng, Yanjun
    Zhu, Jieyu
    Liu, Guixia
    Tang, Yun
    Li, Weihua
    JOURNAL OF APPLIED TOXICOLOGY, 2024, 44 (07) : 1050 - 1066
  • [4] Inhibition of recombinant cytochrome p450 isoforms 2D6 and 2C9 by diverse drug-like molecules
    McMasters, Daniel R.
    Torres, Rhonda A.
    Crathern, Susan J.
    Dooney, Deborah L.
    Nachbar, Robert B.
    Sheridan, Robert P.
    Korzekwa, Kenneth R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (14) : 3205 - 3213
  • [5] Inhibition of human cytochrome P450 2D6 by schering 66712
    Butler, Brendan Francis
    Palamanda, Jairam
    Nomeir, Amin A.
    Guengerich, F. Peter
    Furge, Laura Lowe
    FASEB JOURNAL, 2007, 21 (05): : A670 - A670
  • [6] Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism A retrospective study
    Naujokaitis, Domas
    Asmoniene, Virginija
    Kadusevicius, Edmundas
    MEDICINE, 2021, 100 (11) : E24545
  • [7] Cytochrome P450 2D6
    Owen, Ryan P.
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (07): : 559 - 562
  • [8] INHIBITION OF HUMAN CYTOCHROME P450 2D6 (CYP2D6) BY METHADONE
    WU, D
    OTTON, SV
    SPROULE, BA
    BUSTO, U
    INABA, T
    KALOW, W
    SELLERS, EM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (01) : 30 - 34
  • [9] Predicting Drug Metabolism by Cytochrome P450 2C9: Comparison with the 2D6 and 3A4 Isoforms
    Rydberg, Patrik
    Olsen, Lars
    CHEMMEDCHEM, 2012, 7 (07) : 1202 - 1209
  • [10] Kinetics of cytochrome p450 2C9 inhibition by fluoxetine and norfluoxetine
    Tracy, TS
    Grimm, DL
    FASEB JOURNAL, 2003, 17 (04): : A611 - A611